Screening for Dysglycemia During Postpartum Period in Women With GDM

Recruiting N/A Interventional Study
Gestational Diabetes Mellitus (GDM)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
182 (estimated)
Sponsor
University of Sao Paulo General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Gestational diabetes mellitus (GDM) is one of the most common clinical conditions in pregnancy, with an increasing incidence due to the rise in overweight women and the postponement of motherhood. It is associated with perinatal complications and an increased risk of developing prediabetes and type 2 diabetes after delivery. Therefore, it is recommended that a 75g oral glucose tolerance test (OGTT…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of gestational diabetes mellitus, according to diagnostic criteria proposed by the IADPSG, namely: * initial fasting blood glucose ≥ 92mg/dL OR * 75g oral glucose tolerance test with fasting ≥ 92mg/dL or after 1h ≥ 180mg/dL or after 2h ≥ 153mg/dL Delivery performed a…
Contacts

Tatiana A Zaccara, MD PhD

+551126616209

tatiana.assuncao@hc.fm.usp.br

CONTACT